Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial

Tetsuo Takehara, Naoya Sakamoto, Shuhei Nishiguchi, Fusao Ikeda, Tomohide Tatsumi, Yoshiyuki Ueno, Hiroshi Yatsuhashi, Yasuhiro Takikawa, Tatsuo Kanda, Minoru Sakamoto, Akihiro Tamori, Eiji Mita, Kazuaki Chayama, Gulan Zhang, Shampa De-Oertel, Hadas Dvory-Sobol, Takuma Matsuda, Luisa M. Stamm, Diana M. Brainard, Yasuhito TanakaMasayuki Kurosaki

Research output: Contribution to journalArticlepeer-review

51 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Efficacy and safety of sofosbuvir–velpatasvir with or without ribavirin in HCV-infected Japanese patients with decompensated cirrhosis: an open-label phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences